Met Life Investment Management, LLC Citius Pharmaceuticals, Inc. Transaction History

Met Life Investment Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Apr 29, 2024	BUY	$1.08 - $1.65 $75,324 - $115,079	69,745 New	69,745 $83,000
Q2 2023 Aug 10, 2023	BUY	$1.08 - $1.65 $75,324 - $115,079	69,745 New	69,745 $83,000
Q3 2021 Nov 15, 2021	SELL	$1.74 - $2.6 $88,990 - $132,974	-51,144 Closed	0 $0
Q2 2021 May 17, 2024	BUY	$1.51 - $4.23 $77,227 - $216,339	51,144 New	51,144 $177,000
Q2 2021 Jun 21, 2023	BUY	$1.51 - $4.23 $77,227 - $216,339	51,144 New	51,144 $177,000
Q2 2021 Mar 22, 2023	BUY	$1.51 - $4.23 $77,227 - $216,339	51,144 New	51,144 $177,000
Q2 2021 Aug 16, 2021	BUY	$1.51 - $4.23 $77,227 - $216,339	51,144 New	51,144 $178,000

23.7M

83.1K

32.1K

Ticker CTXR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 146,130,000
Market Cap $457M
Description
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Met Life Investment Management, LLC with notifications on news.